Eli Lilly and Company 8-K

Summary

2026 annual meeting shareholder vote. Shareholders did not approve proposals to eliminate the classified board or supermajority voting provisions; both required support from 80% of outstanding shares.

Key Figures

• The two governance proposals received votes in favor equal to 70.4% and 70.3% of outstanding shares, respectively, below the 80% threshold.
• 847.3M shares were voted, representing approximately 90% of shares entitled to vote.
• All four director nominees were elected, executive compensation was approved on an advisory basis, and Ernst & Young LLP was ratified as auditor; both other shareholder proposals were rejected.